Immutep (IMMP) Cash & Equivalents (2017 - 2025)

Immutep's Cash & Equivalents history spans 9 years, with the latest figure at $43.2 million for Q2 2025.

  • For Q2 2025, Cash & Equivalents fell 59.51% year-over-year to $43.2 million; the TTM value through Jun 2025 reached $43.2 million, down 59.51%, while the annual FY2025 figure was $43.2 million, 59.51% down from the prior year.
  • Cash & Equivalents reached $43.2 million in Q2 2025 per IMMP's latest filing, down from $106.6 million in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $106.6 million in Q2 2024 to a low of $43.2 million in Q2 2025.
  • Average Cash & Equivalents over 5 years is $67.2 million, with a median of $57.3 million recorded in 2022.
  • Peak YoY movement for Cash & Equivalents: skyrocketed 170.46% in 2021, then crashed 59.51% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $46.7 million in 2021, then rose by 22.8% to $57.3 million in 2022, then surged by 43.96% to $82.5 million in 2023, then grew by 29.26% to $106.6 million in 2024, then crashed by 59.51% to $43.2 million in 2025.
  • Per Business Quant, the three most recent readings for IMMP's Cash & Equivalents are $43.2 million (Q2 2025), $106.6 million (Q2 2024), and $82.5 million (Q2 2023).